Assessing vaccine introduction and uptake timelines in Gavi-supported countries: are introduction timelines accelerating across vaccine delivery platforms?

Autor: Luthra K; International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.; Vaccines & Sustainability, GAVI Alliance, Geneva, Geneva, Switzerland., Zimmermann Jin A; (Formerly Applied Strategies), Strategic Decisions Group, Palo Alto, California, USA.; Skoll Foundation, Palo Alto, California, USA., Vasudevan P; International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.; Center for Health Security, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA., Kirk K; International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.; ESS, Cherry Hill, New Jersey, USA., Marzetta C; (Formerly Applied Strategies), Strategic Decisions Group, Palo Alto, California, USA., Privor-Dumm L; International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA lprivor1@jhu.edu.; International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Publikováno v: BMJ global health [BMJ Glob Health] 2021 May; Vol. 6 (5).